False
Avni P. Finn, MD, MBA, FASRS is an Associate Professor at Vanderbilt Eye Institute, Vanderbilt University Medical Center, where she is a board-certified ophthalmologist specializing vitreoretinal diseases and surgery.
Financial disclosures: Consultant: Genentech, Bausch+Lomb, EyePoint, Regenxbio; Advisory board: Annexon, Genentech, Abbvie, Apellis, Iveric Bio
July 30, 2026
An overview of nonclinical data supporting vorolanib’s multi-mechanism of action (MOA) and key findings from the phase 2 DAVIO 2 and VERONA clinical trials, presented at the 44th Annual American Society of Retina Specialists Meeting (July 15–18, 2026; Montréal, Canada).
6 min read
Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.
False